Ophthalmology Doctors in Oxford, MS Accepting Medicare

10 Ophthalmology doctors found. Showing 1 - 10

Randy K Richardson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551

Thomas M Tann Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551

Dr. Emily Taylor Graves, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551

Blake A Booth, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1308 Belk Blvd, Oxford, MS 38655 Phone: 662-234-6551    Fax: 662-234-0468

Dr. William Sumners Mayo, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1628 Highway 30 East, Oxford, MS 38655 Phone: 662-234-3937    Fax: 662-234-3898

Dr. James W Rayner, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1308 Belk Blvd, Oxford, MS 38655 Phone: 662-234-6551

Mr. James Byron Shipp, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1628 Highway 30 East, Oxford, MS 38655 Phone: 662-234-3937    Fax: 662-234-3898

Dr. Randy Herschel Russell, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1308 Belk Blvd, Oxford, MS 38655 Phone: 662-234-6551    Fax: 662-234-0468

William Doty Farmer, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551

Jonathan Zoghby, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2606 S. Lamar, Oxford, MS 38655 Phone: 662-234-6551    Fax: 662-234-0468

News Archive

Lung cancer patients who experience anxiety and depression more likely to die sooner, study reveals

Patients who experience anxiety and depression after being diagnosed with advanced lung cancer are more likely to die sooner, according to new research from the University of British Columbia and BC Cancer Agency.

NEJM publishes results from SOLO I Phase 3 clinical trial of ORBACTIV for ABSSSI

The Medicines Company today announced the publication of the results from the SOLO I Phase 3 clinical trial of ORBACTIV (oritavancin), an investigational intravenous antibiotic treatment for Acute Bacterial Skin and Skin Structure Infections (ABSSSI), in the New England Journal of Medicine.

New 'Fast Track' total hip replacement effective in reducing hospital stay

Discharged from the hospital within two days of a total hip replacement operation? It's possible, thanks to the new 'Fast Track' protocol that underwent testing in the U.S., in response to both patient requests for shorter hospital stays and economic realities of providing medical care.

The doctor pay fix: Medicare's Groundhog Day

NPR reports on the delayed fix for Medicare physician payments, "Medicare's version of Groundhog Day."

Read more Medical News

› Verified 7 days ago